Healthcare -
Biotechnology - NASDAQ - CH
$ 44.04
0.273 %
$ 3.78 B
Market Cap
-10.15
P/E
CRSP - COST OF REVENUE
Cost of Revenue CRSP - CRISPR Therapeutics AG
-2.31 M
LAST VALUE
-1.04%
2 YEAR CAGR
-0.26%
5 YEAR CAGR
-9.72%
10 YEAR CAGR